[1]
|
K. Dégardina, Y. Roggoaand and P. Margot, “Understanding and Fighting the Medicine Counterfeit Market,” In Press for Journal of Pharmaceutical and Biomedical Analysis, 2013. doi:10.1016/j.jpba.2013.01.009
|
[2]
|
T. K. Mackey and B. A. liang, “The Global Counterfeit Drug Trade: Patient Safety and Public Health Risks,” Journal of Pharmaceutical Sciences, Vol. 100, No. 11, 2011, pp. 4571-4579. doi:10.1002/jps.22679
|
[3]
|
J. M. Caudron, N. Ford, M. Henkens, C. Macé, R. Kiddle-Monroeand and J. Pine, “Substandard Medicines in Resource-Poor Settings: A Problem That Can No Longer be Ignored,” Tropical Medicine and International Health, Vol. 13, No. 8, 2008, pp. 1062-1072.
doi:10.1111/j.1365-3156.2008.02106.x
|
[4]
|
O. Shakoor, R. B. Taylor and R. H. Behrens, “Assessment of the Incidence of Substandard Drugs in Developing Countries,” Tropical Medicine and International Health, Vol. 2, No. 9, 1997, pp. 839-845.
doi:10.1046/j.1365-3156.1997.d01-403.x
|
[5]
|
F. M. Fernandez, D. Hostetler, K. Powell, H. Kaur, M. D. Green, D. C. Mildenhall and P. N. Newton, “Poor Quality Drugs: Grand Challenges in High Throughput Detection, Countrywide Sampling, and Forensics in Developing Countries,” Analyst, Vol. 136, No. 15, 2011, pp. 3073-3082. doi:10.1039/c0an00627k
|
[6]
|
P. N. Newton, A. A. Amin, C. Bird, P. Passmore, G. Dukes, G. Tomson, B. Simons, R. Bate, P. J. Guerin and N. J. White, “The Primacy of Public Health Considerations in Defining Poor Quality Medicines,” PLoS Medicine, Vol. 8, No. 12, 2011, Article No: e1001139.
doi:10.1371/journal.pmed.1001139
|
[7]
|
H. M. J. Khojah, H. Pallos, N. Yoshida, M. Akazawa, H. Tsuboi and K. Kimura, “The Quality of Medicines in Community Pharmacies in Riyadh, Saudi Arabia: A Lot Quality Assurance Sampling (LQAS)-Based Survey,” unpublished, under reviewing.
|
[8]
|
B. Crichton, “Keep in a Cool Place: Exposure of Medicines to High Temperatures in General Practice during a British Heat wave,” Journal of the Royal Society of Medicine, Vol. 97, No. 7, 2004, pp. 328-329.
doi:10.1258/jrsm.97.7.328
|
[9]
|
K. K. Naidoo, P. Nompuku, S. N. Mkalali, K. Shabangu, L. Nkabinde and V. Singh, “Post-Marketing Stability Surveillance: Amoxicillin,” South African Family Practice, Vol. 48, No. 6, 2006, p. 14.
|
[10]
|
R. Ziance, C. Chandler and R. H. Bishara, “Integration of Temperature-Controlled Requirements into Pharmacy Practice,” Journal of the American Pharmacists Association, Vol. 49, No. 3, 2003, pp. 61-67.
doi:10.1331/JAPhA.2009.08140
|
[11]
|
Saudi Food and Drug Authority (SFDA), “Operational Regulations of the System for Private Pharmaceutical Facilities and Products,” in Arabic, accessed 2013 May 10.
http://sfda.gov.sa/ar/drug/drug_reg/DocLib/ExecutiverolesforInstitutionsandPharmaceuticalProductslaw.pdf
|
[12]
|
A. A. B. Abdulhak, M. A. Altannir, M. A. Almansor, M. S. Almohaya, A. S. Onazi, M. A. Marei, O. F. Aldossary, S. A. Obeidat, M. A. Obeidat, M. S. Riaz and I. M. Tleyjeh, “Non Prescribed Sale of Antibiotics in Riyadh, Saudi Arabia: A Cross Sectional Study,” BMC Public Health, Vol. 11, 2011, p. 538.
doi:10.1186/1471-2458-11-538
|
[13]
|
T. A. O. Najjar, “A Survey on Community Pharmacies in Riyadh, Saudi Arabia,” Saudi Pharmaceutical Journal, Vol. 9, No. 2, 2001, pp. 113-118.
|
[14]
|
Z. A. Butt, A. H. Gilani, D. Nanan, A. L. Sheikh and F. White, “Quality of Pharmacies in Pakistan: A Cross-Sectional Survey,” International Journal for Quality in Health Care, Vol. 17, No. 4, 2005, pp. 307-313.
doi:10.1093/intqhc/mzi049
|
[15]
|
L. Syhakhang, B. Stenson, R. Wahlstrom and G. Tomson, “The Quality of Public and Private Pharmacy Practices,” European Journal of Clinical Pharmacology, Vol. 57, No. 3, 2001, pp. 221-227. doi:10.1007/s002280100295
|
[16]
|
World Health Organization, “WHO Expert Committee on Specifications for Pharmaceutical Preparations,” Thirty-Seventh Report, World Health Organization, 2004, pp. 125-136, Accessed 2013 May 10.
http://whqlibdoc.who.int/trs/who_trs_908.pdf
|
[17]
|
World Health Organization, “WHO Expert Committee on Specifications for Pharmaceutical Preparations,” Fortieth Report, World Health Organization, 2006, pp. 179-202. Accessed 2013 May 10.
http://whqlibdoc.who.int/trs/who_trs_937_eng.pdf
|